Sukus,
In you're post, saying $45 billion after UK approval is working counter to saying real values are hidden and will be revealed long term. I believe you're right about things being revealed long term and that's when a price like $45 billion could apply. Immediately after UK approval, unless other things have been revealed before it, I don't see our market cap exceeding the $5 to $10 billion range, and may not go that high.
Much could happen before the UK approval, but we don't know that it will, we almost certainly will get an Annual Report, but it's LP's choice as to how open she wishes to be in that report. I really don't see her providing a lot of guidance to investors until she's also ready to hold an Annual Meeting which could come before, after, or simultaneously with the Annual Report, which should come in late February or early March. It's not completely impossible that LP will delay the Annual Meeting until the UK acts, she's ignored the deadline for doing it already and no one seems to be willing to force the issue.
I believe the guidance we get from the Annual Meeting will say a great deal about how quickly the hidden value in the company will be revealed. If we're told that new trials will be started shortly to establish the tumor agnostic label for DCVax-L, that could be big, it could get dramatically bigger if she indicated these trials are going to be co-sponsored with BP's who'll be using their products in combination with our vaccine. If it were also announced that all trials will utilize the EDEN for vaccine manufacture, that would be big, but even bigger if she said it's now also cleared for commercial production. Finally she could say when other regulators will be approached, or perhaps even announce that filings have already been made.
My point is, there is so much that may, or may not be revealed by the time we get UK approval, I don't think that we can estimate how high the market price, or a partnership or buyout offer, could be without knowing what will, or won't be revealed by the time we have the UK approval. If we get nothing more than UK approval, a $5 billion market cap would meet my expectations.
Gary
